Active tuberculosis and human immunodeficiency virus co-infection in Israel: A retrospective study

Israel Medical Association Journal

Volumn 12, Issue 2, 2010, Pages 100-103

  Bendayan, Daniele ^a   Littman, Klementy ^a   Polansky, Vladimir ^a  

^a NONE

Author keywords

Directly observed therapy; Human immunodeficiency virus; Israel; Tuberculosis

Indexed keywords

ADULT; ARTICLE; CONGENITAL HYPOTHYROIDISM; CONTROLLED STUDY; DISEASE REGISTRY; ETHIOPIA; FEMALE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISRAEL; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; OUTCOME ASSESSMENT; POPULATION RESEARCH; TREATMENT OUTCOME; TREATMENT RESPONSE; TUBERCULOSIS; USSR;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CHILD; CHILD, PRESCHOOL; DIRECTLY OBSERVED THERAPY; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; ISRAEL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 77449109353     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence prevalence and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999; 282: 677-86.
2. Corbett EL,Steketee RW, Ter Kuile FO, Latif AS, Kamali A, Hayes RJ. HIV/AIDS and the control of other infectious diseases in Africa. Lancet 2002; 359: 2177-87.
3. Havlir DV, Barnes P. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1999; 340: 367-73.
4. American Thoracic Society/Centers for Disease Control and Prevention/ Infectious Diseases Society of America. Treatment of Tuberculosis. Am J Respir Crit Care Med 2003; 167: 603-62.
5. Cahn P, Perez H, Ben G, Ochoa C. Tuberculosis and HIV: a partnership against the most vulnerable. J Int Assoc Physician AIDS Care 2003; 2: 106-23.
6. Barnes PF, Lakey DL, Burman WJ. Tuberculosis in patients with HIV infection. Infect Dis Clin North Am 2002; 16: 107-26.
7. Chemtob D, Grossman Z. Epidemiology of adult and adolescent HIV infection in Israel: a country of immigration. Int J STD AIDS 2004; 15: 691-6.
8. Chemtob D. HIV/AIDS in Israel. Epidemiological periodic report 1281-2007. www.health.gov.il/TBAIDS
9. Aaron L, Saadoun D, Calatroni I, et al, Tuberculosis in HIV-infected patients: a comprehensive review. Clin Microbiol Infect 2004; 10: 388-98.
10. Jones BE, Young SMM, Antoniskis D, et al. Relationship of the manifestations of tuberculosis to the CD4 sells count in patients with the human immunodeficiency virus infection. Am Rev Respir Dis 1995; 193: 115-19.
11. Managing Drug Interactions in the Treatment of HIV related Tuberculosis. CDC 2007. http://www.cdc.gov/tb/TB
12. Nava E, Martin Devila P, Morino L, et al. Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy. Arch Intern Med 2002; 162: 97-9.
13. Wendel KA, Alwood KS, Gachuhi R, Chaisson RE, Bishai WR, Sterling TR. Paradoxical worsening of tuberculosis in HIV infected persons. Chest 2001; 120: 193-7.
14. Kitahata MM, Eron JJ, Reiss P, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009; 360: 1815-26.
15. Piscitelli SC, Gallicano KD. Interactions among drugs for HIV and opportunistic infections. N Engl J Med 2001; 344: 984-96.
16. Breen RA, Swaden L, Ballinger J, Lipman MC. Tuberculosis and HIV co-infection: a practical therapeutic approach. Drugs 2006; 66: 2299-308.
17. Manosuthi W, Sungkanuparph S, Thakkinstian A, et al. Efavirenz levels and 24 week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampin. AIDS 2005; 19: 1481-6.